SCHEMBL6184532

SCHEMBL6184532

CCc1ccc(CC=O)cc1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.41
BACE1 P56817 1/20 0.37
GPR84 Q9NQS5 2/20 0.33
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
TRPA1 O75762 1/20 0.32
ALDH1A1 P00352 4/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
SRC P12931 1/20 0.32
HPGD P15428 1/20 0.32
NPC1 O15118 1/20 0.31
MAPK1 P28482 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664442 0.88 EGFR (0.38) DHFRBACE1GPR84TRPA1ALDH1A1
SCHEMBL12802185 0.83 ALDH1A1 (0.48) DHFRALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL4765688 0.83 DHFR (0.36) DHFRBACE1ALDH1A1MAPTCA2
SCHEMBL13586648 0.81 TRPA1 (0.47) BACE1TRPA1ALDH1A1LMNAMAPT
SCHEMBL6181671 0.81 BACE1 (0.38) DHFRBACE1LMNAMAPTSMN1; SMN2
SCHEMBL4706066 0.81 BACE1 (0.59) BACE1TRPA1ALDH1A1LMNAMAPT
SCHEMBL6180538 0.81 KDM4C (0.34) BACE1LMNAMAPTMAPK1L3MBTL1
SCHEMBL444673 0.80 TRPA1 (0.48) DHFRBACE1TRPA1ALDH1A1LMNA
Formic Acid SCHEMBL28752897 0.80 TRPA1 (0.45) DHFRBACE1GPR84TRPA1ALDH1A1
SCHEMBL10225859 0.78 SRC (0.41) ALDH1A1LMNAMAPTSMN1; SMN2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1529038-A1 BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY Novartis AG (CH) 2005-05-11 EP disclosed
WO-2004016601-A1 BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY NOVARTIS AG (CH) 2004-02-26 WO disclosed